Treatment of Epstein–Barr Virus-associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: A case report and literature review

By Zhu Kanger   Chen Jie   Chen Shengting  

Hematology, Vol. 10, Iss. 5, 2005-10 ,pp. : 365-370

Maney Publishing

Access to resources Recommend Favorite

Influence of Epstein–Barr virus infection in adult T-cell leukemia

By Ueda Satomi   Maeda Yasuhiro   Yamaguchi Terufumi   Hanamoto Hitoshi   Hijikata Yasuki   Tanaka Miyako   Takai Shunsuke   Hirase Chikara   Morita Yasuyoshi   Kanamaru Akihisa  

Hematology, Vol. 13, Iss. 3, 2008-06 ,pp. : 154-162

Maney Publishing

Access to resources Recommend Favorite

The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopenia

By Wu Zhong   Zhou Jin   Wei Xiaoxia   Wang Xin   Li Yongbin   Peng Bing   Niu Ting  

Hematology, Vol. 18, Iss. 5, 2013-09 ,pp. : 295-299

Maney Publishing

Access to resources Recommend Favorite

Lytic infection of Epstein-Barr virus (EBV) in hemophagocytic syndrome associated with EBV-induced lymphoproliferative disorder

By Yamamoto T.  

Annals of Hematology, Vol. 83, Iss. 2, 2004-02 ,pp. : 127-132

Springer Publishing Company

Access to resources Recommend Favorite

CD4+ T Cell Responses in the Immune Control Against Latent Infection by Epstein-Barr Virus

By  

Current Molecular Medicine, Vol. 3, Iss. 4, 2003-06 ,pp. : 341-347

Bentham Science Publishers

Access to resources Recommend Favorite